Latest News
Pharma
Medtech
Biotech
Science
Careers
Events
Advertising
Press Rooms
Login
Subscribe

Facebook Like

Nordic Life Science

Search for content, post, videos

Subscribe
My account

Business
Pharma
Medtech
Biotech
Science
Careers
Events
Press Rooms
Advertising
About us
Subscribe
Login

Search for content, post, videos

Tag

prio-drug-device

Nordic Nanovector

Nordic Nanovector to discontinue the PARADIGME trial

July 12, 2022

Nordic Nanovector has provided an …

Read this next

A high-level take on recent trends in healthcare

January 25, 2023
AI Medical Technology nets 10.8 million SEK

January 25, 2023
Science Q&A: Does evolution have a built-in preference for symmetry?

January 24, 2023
Modus Therapeutics submits patent application

January 23, 2023
Ultimovacs completes patient recruitment in Phase II trial

January 23, 2023
Evaxion receives FDA fast-track designation

January 20, 2023

Nordic Life Science in Social Media

Twitter Follow

NLS insight

Cancer immunotherapy

A paradigm shift in cancer treatment

Read more

Editor in Chief/Web Editor

Sales & Marketing

Product manager

Subscription and customer support

+46 8 588 941 51

Postal address:

NLS Media Group AB

PO Box 2158

103 14 Stockholm

Follow @NLifeScience

NLS Media Group AB – Postal address: Kindstugatan 1, 111 31 Stockholm. Phone: +46 8 588 941 50